Company page

Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H

Hanx Biopharmaceuticals (Wuhan) Co. Ltd. Class H, trading under the ticker 3378 on the Hong Kong market, has a market capitalization of approximately 467.4 million. The company focuses on developing innovative biopharmaceutical products. Its strategic initiatives aim to enhance healthcare solutions and improve patient outcomes.

profile3378:HKEXAI content: aiUpdated June 24, 2026/company/xiamen-international-port-co-ltd/c-p6nlcsgb
Hanx Biopharmaceuticals (wuhan) Co. Ltd. Class H logo
Ticker
3378:HKEX
Asset type
Stock
Market cap
$467.4M
Sector
Health Technology
Industry
Biotechnology
Exchange
HKEX
Currency
HKD